Botulinum Toxin for Pelvic Pain in Women With Endometriosis

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1/PHASE2

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-07-30

Study Completion Date

2019-07-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background:

\- Some women with endometriosis have chronic pelvic pain. This pain may be caused by spasms of the pelvic floor muscles. These spasms can be detected by an examination. Studies suggest that botulinum toxin can help treat problems caused by muscle spasms. Researchers want to see if botulinum toxin injections into the pelvic floor muscles can decrease pain and spasms in women with pelvic pain.

Objectives:

\- To see if botulinum toxin can relieve pain from pelvic floor spasm in women with pelvic pain.

Eligibility:

\- Women between 18 and 50 years of age with pain associated with pelvic muscle spasm and endometriosis. Pain must be persistent (lasting for at least 3 months).

Design:

* Participants will keep a pain diary and record their pain medication use for a month before the first visit.
* Participants will be screened with a physical exam and medical history. Blood and urine samples will be collected. Participants will also answer questions about their pain levels and quality of life.
* Participants will receive either botulinum toxin or a placebo (salt water) injection. The injection will be given into the pelvic floor muscles through the vaginal wall. Participants will take a muscle relaxant like Valium and have anesthetic cream put on the vaginal wall before the injection.
* After the injection, participants will keep a pain diary for another month.
* At a 1-month followup visit, participants will answer questions about their pain. If the pain has not improved, all participants may have a botulinum toxin injection (no placebo) into the pelvic floor muscles as before.
* Participants will have followup visits for up to a year after the initial 1-month followup visit.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Injection With OnabotulinumtoxinA (Botox) for the Treatment of Chronic Pelvic Pain

NCT02173405

Myofascial Pain Syndromes Myofascial Trigger Point Pain Trigger Point Pain, Myofascial

COMPLETED PHASE1

Botulinum Toxin Type A Versus Saline Trigger Point Injections for Myofascial Pelvic Pain

NCT01905137

Myofascial Pelvic Pain

UNKNOWN NA

Botox as a Treatment for Interstitial Cystitis in Women

NCT00194610

Painful Bladder Syndrome Interstitial Cystitis

COMPLETED PHASE4

Electromyographic Study for the Help and Guidance of BoNTA Administration in the Treatment of Chronic Pelvic Floor Pain

NCT03715777

Electromyography EMG: Myopathy EMG Syndrome +4 more

COMPLETED PHASE3

Placebo-controlled RCT of Botulinum Toxin A as a Treatment for Provoked Vestibulodynia

NCT02773641

Vulvodynia

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Chronic pelvic pain associated with endometriosis is poorly understood. Some women with chronic pelvic pain have muscle spasm of their pelvic muscles. Muscle spasm may be a significant part of pain in women with endometriosis and other types of chronic pelvic pain. Botulinum toxin injection is widely used to treat conditions associated with excessive muscle activity and spasm. Studies of botulinum toxin injected into pelvic muscles of women with pelvic pain have shown a decrease pain and spasm, but too few women have been studied to conclude its effectiveness. We expect to show that botulinum toxin injection in women with pelvic pain will relieve some of their pelvic pain.

Eligible subjects will be otherwise healthy women who have chronic pelvic pain and a history of endometriosis. Subjects will be randomized to either botulinum toxin injection or placebo (salt water) injection. After one month, we will evaluate the presence of the pain and all women will be offered botulinum toxin injection. We will also evaluate the need for reinjection.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Endometriosis Chronic Pelvic Pain Pelvic Muscle Spasm Quality of Life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Botulinum toxin (BoNT)

OnabotulinumtoxinA 100 Units diluted in 4cc saline, one time intramuscular administration

Group Type EXPERIMENTAL

Botulinum toxin (BoNT)

Intervention Type DRUG

OnabotulinumtoxinA 100 Units diluted in 4cc saline, one time intramuscular administration

Placebo

Saline, 4cc, one time intramuscular administration

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Saline, 4cc, one time intramuscular administration

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Botulinum toxin (BoNT)

OnabotulinumtoxinA 100 Units diluted in 4cc saline, one time intramuscular administration

Intervention Type DRUG

Placebo

Saline, 4cc, one time intramuscular administration

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female gender
* Age between 18 and 55
* History of endometriosis at surgery
* Persistent pelvic pain for at least 3 months
* Pelvic floor spasm
* Negative pregnancy test (in women who have not had a hysterectomy)
* Willing to use reliable method of contraception for the month after botulinum toxin injection including oral contraceptives, IUD, and barrier with spermicide.
* Willing and able to give informed consent
* Willing and able to comply with study requirements

Exclusion Criteria

* Women with other causes of chronic pelvic pain including infectious, gastrointestinal, psychological disorders, fibromyalgia and chronic fatigue syndrome based on review of medical history within 1 year of first study visit,
* Untreated severe cervical dysplasia or other gynecologic condition clinically significant abnormalities on physical or laboratory examinations that require evaluation or treatment or that would make participation unsafe
* Hysterectomy and bilateral salpingo-oophorectomy
* Pregnancy
* Lactation
* Allergy to albumen or botulinum toxin
* Presence of antibodies to botulinum toxin or loss of response to previous injections for any indication
* A known neuromuscular junction disorder such as myasthenia gravis or Eaton-Lambert syndrome
* History of urinary or fecal incontinence
* Known pelvic prolapse

* Eligibility will be based on a physical exam at NIH at the first study visit, as well as history and available medical records within 1 year before the study visit. Negative test results will be documented to confirm study eligibility. If the Pap and the GC and chlamydia tests were not done outside of the NIH within the previous year, or if documentation of the negative test results is not available, we will await the results of the screening tests done at the NIH before administering the study medication.

Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No